These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19537364)

  • 1. Advances in treatment for neurotrophic keratopathy.
    Nishida T; Yanai R
    Curr Opin Ophthalmol; 2009 Jul; 20(4):276-81. PubMed ID: 19537364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurotrophic keratopathy--studies on substance P and the clinical significance of corneal sensation].
    Nishida T; Nakamura M; Konma T; Ofuji K; Nagano K; Tanaka T; Enoki M; Reid TW; Brown SM; Murphy CJ; Mannis MJ
    Nippon Ganka Gakkai Zasshi; 1997 Dec; 101(12):948-74. PubMed ID: 9436358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of corneal epithelial barrier function and wound healing by substance P and IGF-1 in rats with capsaicin-induced neurotrophic keratopathy.
    Nakamura M; Kawahara M; Nakata K; Nishida T
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2937-40. PubMed ID: 12824234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy.
    Nagano T; Nakamura M; Nakata K; Yamaguchi T; Takase K; Okahara A; Ikuse T; Nishida T
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3810-5. PubMed ID: 12939296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotrophic keratopathy; its pathophysiology and treatment.
    Okada Y; Reinach PS; Kitano A; Shirai K; Kao WW; Saika S
    Histol Histopathol; 2010 Jun; 25(6):771-80. PubMed ID: 20376784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential New Modes of Treatment of Neurotrophic Keratopathy.
    Yanai R; Nishida T; Chikama T; Morishige N; Yamada N; Sonoda KH
    Cornea; 2015 Nov; 34 Suppl 11():S121-7. PubMed ID: 26448169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the Neurokinin-1 Receptor in the Promotion of Corneal Epithelial Wound Healing by the Peptides FGLM-NH2 and SSSR in Neurotrophic Keratopathy.
    Yanai R; Nishida T; Hatano M; Uchi SH; Yamada N; Kimura K
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):29. PubMed ID: 32697304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
    Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A
    Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent epithelial defects due to neurotrophic keratopathy treated with a substance p-derived peptide and insulin-like growth factor 1.
    Nishida T; Chikama T; Morishige N; Yanai R; Yamada N; Saito J
    Jpn J Ophthalmol; 2007; 51(6):442-7. PubMed ID: 18158595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1.
    Brown SM; Lamberts DW; Reid TW; Nishida T; Murphy CJ
    Arch Ophthalmol; 1997 Jul; 115(7):926-7. PubMed ID: 9230840
    [No Abstract]   [Full Text] [Related]  

  • 11. [The cornea: stasis and dynamics].
    Nishida T
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):179-212; discussion 213. PubMed ID: 18411711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I.
    Chikama T; Fukuda K; Morishige N; Nishida T
    Lancet; 1998 Jun; 351(9118):1783-4. PubMed ID: 9635953
    [No Abstract]   [Full Text] [Related]  

  • 13. Peptide therapies for ocular surface disturbances based on fibronectin-integrin interactions.
    Nishida T; Inui M; Nomizu M
    Prog Retin Eye Res; 2015 Jul; 47():38-63. PubMed ID: 25645519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational research in corneal epithelial wound healing.
    Nishida T
    Eye Contact Lens; 2010 Sep; 36(5):300-4. PubMed ID: 20724848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P, insulinlike growth factor 1, and surface healing.
    Lee CH; Whiteman AL; Murphy CJ; Barney NP; Taylor PB; Reid TW
    Arch Ophthalmol; 2002 Feb; 120(2):215-7. PubMed ID: 11831929
    [No Abstract]   [Full Text] [Related]  

  • 16. New therapeutic approaches in the treatment of diabetic keratopathy: a review.
    Abdelkader H; Patel DV; McGhee CNj; Alany RG
    Clin Exp Ophthalmol; 2011 Apr; 39(3):259-70. PubMed ID: 20973888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the C domain of IGFs in synergistic promotion, with a substance P-derived peptide, of rabbit corneal epithelial wound healing.
    Yamada N; Yanai R; Nakamura M; Inui M; Nishida T
    Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1125-31. PubMed ID: 15037578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect with Phe-Gly-Leu-Met-NH2 of the C-terminal of substance P and insulin-like growth factor-1 on epithelial wound healing of rabbit cornea.
    Nakamura M; Chikama T; Nishida T
    Br J Pharmacol; 1999 May; 127(2):489-97. PubMed ID: 10385250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotrophic mediators and corneal wound healing.
    Nishida T
    Ocul Surf; 2005 Oct; 3(4):194-202. PubMed ID: 17131028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal epithelial and neuronal interactions: role in wound healing.
    Kowtharapu BS; Stahnke T; Wree A; Guthoff RF; Stachs O
    Exp Eye Res; 2014 Aug; 125():53-61. PubMed ID: 24880142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.